Comparison of the Effects of Intratympanic Steroid Injection at Different Intervals in Sudden Sensorineural Hearing Loss
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Background and Objectives: Systemic steroid therapy (SST) and intratympanic steroid injection (ISI) have been the treatment of choice for sudden sensorineural hearing loss (SSNHL). We studied the effect of ISI administered at different intervals on hearing outcomes in patients with SSNHL. Subjects and Methods: We performed a retrospective study of 427 patients diagnosed with SSNHL at Bundang Jesaeng Hospital, of whom 51 patients with SSNHL who received SST and four ISIs were included in this study. Patients were treated with four ISIs either every day for 4 days (group 1) or at intervals (mean duration of interval: 2.21 days) (group 2). Hearing outcomes were evaluated using the pure-tone test before the injection and 14 days, 1 month, and 3 months after the final injection. Recovery rates were classified based on Siegel’s criteria. Results: The amount of improvement was 27.67 dB (±20.45) in group 1 and 32.79 dB (±21.42) in group 2. However, there were no significant differences between the two groups (p= 0.714). The recovery rates based on Siegel’s criteria were 18/27 (66.7%) and 16/24 (66.7%) in groups 1 and 2, respectively, with no significant difference (p=1.000). Considering only complete recoveries in hearing recovery, the recovery rates were 15/27 (55.6%) and 14/24 (58.3%) in groups 1 and 2, respectively, with no significant difference (p=0.842). Conclusions: There were no significant differences in hearing outcomes or recovery rates after ISI administration every day or at intervals of 2-3 days.
Abstract
Background and Objectives: Systemic steroid therapy (SST) and intratympanic steroid injection (ISI) have been the treatment of choice for sudden sensorineural hearing loss (SSNHL). We studied the effect of ISI administered at different intervals on hearing outcomes in patients with SSNHL. Subjects and Methods: We performed a retrospective study of 427 patients diagnosed with SSNHL at Bundang Jesaeng Hospital, of whom 51 patients with SSNHL who received SST and four ISIs were included in this study. Patients were treated with four ISIs either every day for 4 days (group 1) or at intervals (mean duration of interval: 2.21 days) (group 2). Hearing outcomes were evaluated using the pure-tone test before the injection and 14 days, 1 month, and 3 months after the final injection. Recovery rates were classified based on Siegel’s criteria. Results: The amount of improvement was 27.67 dB (±20.45) in group 1 and 32.79 dB (±21.42) in group 2. However, there were no significant differences between the two groups (p= 0.714). The recovery rates based on Siegel’s criteria were 18/27 (66.7%) and 16/24 (66.7%) in groups 1 and 2, respectively, with no significant difference (p=1.000). Considering only complete recoveries in hearing recovery, the recovery rates were 15/27 (55.6%) and 14/24 (58.3%) in groups 1 and 2, respectively, with no significant difference (p=0.842). Conclusions: There were no significant differences in hearing outcomes or recovery rates after ISI administration every day or at intervals of 2-3 days.
참고문헌 (14)
- Chau JK, "Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss", Laryngoscope, 120, pp.1011~1021 (2010)
- Vijayendra H, "Sudden sensorineural hearing loss : an otologic emergency", Indian J Otolaryngol Head Neck Surg, 64, pp.1~4 (2012)
- Moskowitz D, "Steroid use in idiopathic sudden sensorineural hearing loss", The Laryngoscope, 94, pp.664~666 (1984)
- Conlin AE, "Treatment of sudden sensorineural hearing loss: II. A Meta-analysis", Arch Otolaryngol Head Neck Surg, 133, pp.582~586 (2007)
- Parnes LS, "Corticosteroid pharmacokinetics in the inner ear fluids : an animal study followed by clinical application", Laryngoscope, 109(7 Pt 2), pp.1~17 (1999)
- Chou YF, "Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss", Laryngoscope, 123, pp.2264~2269 (2013)
- Siegel LG, "The treatment of idiopathic sudden sensorineural hearing loss", Otolaryngol Clin North Am, 8, pp.467~473 (1975)
- Hobson CE, "Primary treatment of idiopathic sudden sensorineural hearing loss with intratympanic dexamethasone", Curr Opin Otolaryngol Head Neck Surg, 24, pp.407~412 (2016)
- Shirwany NA, "Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig", Am J Otol, 19, pp.230~235 (1998)
- Lee JJ, "Steroid intracochlear distribution differs by administration method : systemic versus intratympanic injection", Laryngoscope, 128, pp.189~194 (2018)
- Hargunani CA, "Intratympanic injection of dexamethasone : time course of inner ear distribution and conversion to its active form", Otol Neurotol, 27, pp.564~569 (2006)
- 김영준, "돌발성 난청 환자에서 고실 내 스테로이드 투여 약제에 따른 치료 효과 비교", 대한이비인후-두경부외과학회지, 60(9), pp.441~448 (2017), 대한이비인후과학회[DOI]
- Sugihara EM, "The effect of intratympanic steroid injection frequency in idiopathic sudden sensorineural hearing loss", Am J Otolaryngol, 39, pp.688~692 (2018)
- Suzuki H, "Hearing outcome does not depend on the interval of intratympanic steroid administration in idiopathic sudden sensorineural hearing loss", Eur Arch Otorhinolaryngol, 273, pp.3101~3107 (2016)